[go: up one dir, main page]

RU99116198A - METHOD FOR TREATING SUBCLINIC FORM OF GENITAL HERPESVIRUS INFECTION IN WOMEN - Google Patents

METHOD FOR TREATING SUBCLINIC FORM OF GENITAL HERPESVIRUS INFECTION IN WOMEN

Info

Publication number
RU99116198A
RU99116198A RU99116198/14A RU99116198A RU99116198A RU 99116198 A RU99116198 A RU 99116198A RU 99116198/14 A RU99116198/14 A RU 99116198/14A RU 99116198 A RU99116198 A RU 99116198A RU 99116198 A RU99116198 A RU 99116198A
Authority
RU
Russia
Prior art keywords
women
treating
subclinic
herpesvirus infection
genital
Prior art date
Application number
RU99116198/14A
Other languages
Russian (ru)
Other versions
RU2191576C2 (en
Inventor
Татьяна Викторовна Кузовкова
Надежда Васильевна Щербакова
Любовь Ивановна Юровских
Наталья Петровна Евстигнеева
Original Assignee
Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии
Filing date
Publication date
Application filed by Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии filed Critical Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии
Priority to RU99116198A priority Critical patent/RU2191576C2/en
Priority claimed from RU99116198A external-priority patent/RU2191576C2/en
Publication of RU99116198A publication Critical patent/RU99116198A/en
Application granted granted Critical
Publication of RU2191576C2 publication Critical patent/RU2191576C2/en

Links

Claims (1)

Способ лечения субклинической формы генитальной герпесвирусной инфекции у женщин, включающий применение противовирусных и иммуномодулирующих препаратов, отличающийся тем, что больным назначают валтрекс по 0,5 г 2 раза в день, курс 10 дней, одновременно назначают неовир по 250 мг внутримышечно, 10 инъекций, интервал между инъекциями 48 ч, после окончания приема валтрекса назначают ацилакт в виде влагалищных свечей по 5 доз ежедневно, на ночь, в течение 10 дней.A method of treating a subclinical form of genital herpes virus infection in women, including the use of antiviral and immunomodulating drugs, characterized in that patients are prescribed valtrex 0.5 g 2 times a day, a course of 10 days, at the same time, 250 mg neovir is administered intramuscularly, 10 injections, interval between injections 48 hours, after the end of taking valtrex, acylact is prescribed in the form of vaginal suppositories, 5 doses daily, at night, for 10 days.
RU99116198A 1999-07-27 1999-07-27 Method for treating subclinical form of female genital herpesvirus infection RU2191576C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU99116198A RU2191576C2 (en) 1999-07-27 1999-07-27 Method for treating subclinical form of female genital herpesvirus infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU99116198A RU2191576C2 (en) 1999-07-27 1999-07-27 Method for treating subclinical form of female genital herpesvirus infection

Publications (2)

Publication Number Publication Date
RU99116198A true RU99116198A (en) 2001-05-27
RU2191576C2 RU2191576C2 (en) 2002-10-27

Family

ID=20223095

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99116198A RU2191576C2 (en) 1999-07-27 1999-07-27 Method for treating subclinical form of female genital herpesvirus infection

Country Status (1)

Country Link
RU (1) RU2191576C2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI900412A7 (en) * 1988-05-26 1990-01-25 Nika Health Products Ltd Antiviral or antibacterial compound and method of using it
RU2073520C1 (en) * 1996-05-07 1997-02-20 Сергей Викторович Сорокин Medicinal preparation and method of urogenital infection prophylaxis and treatment

Similar Documents

Publication Publication Date Title
IT1270594B (en) CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION OF LIQUID SUSPENSION MOGUISTEIN
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
EP1449835A3 (en) Alpha-substituted pyrimidine-thioalkyl and alkylether compounds
FR2609632B1 (en) NOVEL THERAPEUTIC APPLICATION OF 17- (CYCLOPROPYLMETHYL) -4,5-EPOXY-3,14-DIHYDROXYMORPHINON-6-ONE AND PHARMACEUTICAL COMPOSITIONS FOR THIS USE
CA2494015A1 (en) Antibiotic product, use and formulation thereof
GB8817015D0 (en) Method of treatment
EP1670507A4 (en) VACCINE FOR THE TREATMENT AND PREVENTION OF INFECTION CAUSED BY HERPES SIMPLEX VIRUS
WO2000016786A3 (en) Oxihumic acid and its use in the treatment of various conditions
RU99116293A (en) METHOD FOR TREATMENT OF RECOVERY GENITAL HERPES IN WOMEN
RU99116198A (en) METHOD FOR TREATING SUBCLINIC FORM OF GENITAL HERPESVIRUS INFECTION IN WOMEN
RU98111152A (en) The use of the active substance flupirtine or its pharmacologically acceptable salts as a drug for the prevention and treatment of diseases associated with damage to the cell system
CA2120001A1 (en) Flavopereirine-based pharmaceutical composition and use thereof for treating hiv
WO1994005300B1 (en) Use of rapamycin in the treatment of aids
FR2644060B1 (en) MEDICINE, ESPECIALLY FOR THE TREATMENT OF CUTANEOUS, EYE AND GENITAL HERPES VIRUS DISEASES
Apoola et al. Antiviral treatment of genital herpes
RU2162687C2 (en) Improved medicinal form of interferon inductor
RU99112967A (en) METHOD FOR TREATMENT AND PREVENTION OF PIG DYSENTERY
RU97112609A (en) METHOD FOR TREATING "METABOLIC SYNDROME X"
RU97118781A (en) 2,4-Dichlorobenzyl alcohol and amylmethacresol against HIV infection
CY2337B1 (en) Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 invection.
UA42944A (en) Method for treatment of damages of uterus cervix caused by herpesvirus
RU98118096A (en) METHOD FOR INCREASING ORGANISM RESISTANCE
RU97117804A (en) METHOD FOR TREATING VIRAL AND CHLAMIDIA INFECTION
RU97112610A (en) METHOD FOR TREATING ARTERIAL HYPERTENSION IN THE CLIMACTERIC PERIOD
BR9607663A (en) Use of penciclovir for the treatment of human herpes virus 8